The degree of potassium channel blockade and the risk of torsade de pointes: The truth, nothing but the truth, but not the whole truth

European Heart Journal

Volumn 26, Issue 6, 2005, Pages 536-537

  Viskin, Sami ^a   Rosovski, Uri ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT;

EDITORIAL; HEART ARREST; HEART ARRHYTHMIA; HIGH RISK PATIENT; PRIORITY JOURNAL; QT INTERVAL; RISK ASSESSMENT; SUDDEN DEATH; TORSADE DES POINTES;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; HUMANS; PIPERAZINES; POTASSIUM CHANNEL BLOCKERS; RESEARCH DESIGN; TORSADES DE POINTES; VERAPAMIL;

EID: 16244373023     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi155     Document Type: Editorial

References (9)

1. Viskin S. The long QT syndromes and torsade de pointes. Lancet 1999;354:1625-1633.
2. Mitcheson JS, Chen J, Lin M et al. A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci USA 2000;97:12329-12333.
3. Viskin S, Justo D, Halkin A et al. Long QT syndrome caused by non-cardiac drugs. Prog Cardiovasc Dis 2003;45:415-427.
4. De Bruin ML, Pettersson M, Meyboom RHB et al. Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death. Eur Heart J 2005;26:590-597. First published on January 6, 2005, doi:10.1093/eurheartj/ehi092.
5. Fenichel RR, Malik M, Antzelevitch C et al. Drug-induced torsades de pointes and implications for drug development. J Cardiovasc Electrophysiol 2004;15:475-495.
6. Yoshida H, Sugiyama A, Satoh Y et al. Comparison of the in vivo electrophysiological and proarrhythmic effects of amiodarone with those of a selective class III drug, sematilide, using a canine chronic atrioventricular block model. Circ J 2002;66:758-762.
7. Antzelevitch C, Belardinelli L, Zygmunt AC et al. Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation 2004;110:904-910.
8. Aiba T, Shimizu W, Inagaki M et al. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil. J Am Coll Cardiol 2005;45:300-307.
9. Zeltser D, Justo D, Halkin A et al. Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors. Medicine (Baltimore) 2003;82:282-290.